From: Tracking of serum lipids from prepuberty to young adulthood: results from the KiGGS cohort study
 | Lipid risk category at follow-upa | N | % (95%-CI) |
---|---|---|---|
Baseline non-HDL-C ≥ 3.76 mmol/la (N = 53) | Acceptable Non-HDL-C | 25 | 47.9 (29.0–67.4) |
 | Borderline Non-HDL-C | 20 | 27.6 (15.9–43.5) |
Elevated Non-HDL-C | 8 | 24.5 (8.9–52.0) | |
Baseline TC ≥ 5.18 mmol/la (N = 70) | Acceptable TC | 21 | 27.2 (16.4–41.5) |
 | Borderline TC | 25 | 29.4 (17.4–45.2) |
Elevated TC | 24 | 23.8 (27.1–61.4) | |
Baseline HDL-C < 1.04 mmol/la (N = 29) | Acceptable HDL-C | 16 | 54.4 (28.8–77.9) |
 | Borderline HDL-C | 7 | 32.4 (12.2–62.4) |
Low HDL-C | 6 | 13.2 (4.5–32.5) |